Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zora Marjanovic

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|April 1, 2021
Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory diseaseTony Huynh, Elise Corre, Marie-Paule Lemonnier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
European Journal of Haematology|December 15, 2020
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphomaZoé Van de Wyngaert, Paul Coppo, Pascale Cervera, et al.
Archives of Internal Medicine|August 3, 2002
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled studyGuy Meyer, Zora Marjanovic, Judith Valcke, et al.
The Journal of Rheumatology|June 18, 2009
Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoringDavid Launay, Zora Marjanovic, Cedric de Bazelaire, et al.
Cancers|February 26, 2025
Risk Assessment Models for Predicting Venous Thromboembolism in Patients with Pancreatic CancerCorinne Frere, Sophie Gourgou, Audrey Winter, et al.
British Journal of Haematology|October 19, 2024
Severe cytopenia after chimeric antigen receptor-T cell driven by large granular lymphocytes and responsive to steroidsAntoine Capes, Alexandra Morin, Anne Banet, et al.
Rheumatology (Oxford, England)|June 10, 2022
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantationGrégory Pugnet, Antoine Petermann, Samia Collot, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
Journal of Hematology & Oncology|January 21, 2017
Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patientsDominique Farge, Lucas C M Arruda, Fanny Brigant, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|April 1, 2021
Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory diseaseTony Huynh, Elise Corre, Marie-Paule Lemonnier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
European Journal of Haematology|December 15, 2020
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphomaZoé Van de Wyngaert, Paul Coppo, Pascale Cervera, et al.
Archives of Internal Medicine|August 3, 2002
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled studyGuy Meyer, Zora Marjanovic, Judith Valcke, et al.
The Journal of Rheumatology|June 18, 2009
Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoringDavid Launay, Zora Marjanovic, Cedric de Bazelaire, et al.
Cancers|February 26, 2025
Risk Assessment Models for Predicting Venous Thromboembolism in Patients with Pancreatic CancerCorinne Frere, Sophie Gourgou, Audrey Winter, et al.
British Journal of Haematology|October 19, 2024
Severe cytopenia after chimeric antigen receptor-T cell driven by large granular lymphocytes and responsive to steroidsAntoine Capes, Alexandra Morin, Anne Banet, et al.
Rheumatology (Oxford, England)|June 10, 2022
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantationGrégory Pugnet, Antoine Petermann, Samia Collot, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
Journal of Hematology & Oncology|January 21, 2017
Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patientsDominique Farge, Lucas C M Arruda, Fanny Brigant, et al.
Pageof 7